Similar Articles
91 Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiome
92 Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection
93 Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
94 Hepatocellular carcinoma in nonalcoholic fatty liver disease: A growing challenge
95 Screening for nonalcoholic fatty liver disease-when, who and how?
96 Effectiveness of drug interventions in nonalcoholic fatty liver disease: A network meta-analysis
97 Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood
98 Nutritional supplement drink reduces inflammation and postoperative depression in patients after off-pump coronary artery bypass surgery
99 Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
100 Psoriasis treatment using minimally manipulated umbilical cord-derived mesenchymal stem cells: A case report
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA